Klaartje Kok

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

Nicholas A. Kennedy, Simeng Lin, James Goodhand et al. · Gut · 2021 · 275 citations · Full text

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 229 citations · Full text

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.

Nicholas A. Kennedy, James Goodhand, Claire Bewshea et al. · Edinburgh Research Explorer (University of Edinburgh) · 2021 · 163 citations · Full text

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

James L. Alexander, Nicholas A. Kennedy, Hajir Ibraheim et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 147 citations · Full text

Kinome Profiling for Studying Lipopolysaccharide Signal Transduction in Human Peripheral Blood Mononuclear Cells

Sander H. Diks, Klaartje Kok, Tom O’Toole et al. · Journal of Biological Chemistry · 2004 · 132 citations · Full text